Healthcare
WHAT WE DO
Providing Differentiated M&A and Capital Advisory Services to Leading Healthcare Companies
The Solomon Partners Healthcare group provides best-in-class M&A and capital advisory services to publicly traded, privately held, and financial sponsor clients across the healthcare landscape. We combine deep industry expertise with proven execution capabilities and a high level of service to deliver superior results to clients across our core coverage areas, which include:
- Healthcare Services
- Medical Devices & Technology
- Contract Manufacturing & Other Outsourced Services
- Healthcare Distribution
- Healthcare Technology
- Outsourced Pharma Services
- Nuclear Medicine & Radiopharmaceuticals
- Specialty & Generic Pharmaceuticals
- Consumer Healthcare/HealthTech
- Pharmacy & Pharmacy Services
Our senior team experience includes some of the most notable healthcare M&A transactions in the past two decades, with a combined transaction value of over $200 billion. The core tenets of our franchise include:
- Deep Industry Expertise: We are the industry experts in our core coverage areas and bring a wealth of experience and expertise to every transaction.
- Full Commitment and Focus: Our senior bankers are intimately involved in every aspect of the M&A process, from preparation to close.
- Execution Excellence: We have an intense, data-centric approach to execution to ensure all bases are covered and no detail goes unnoticed.
- Longstanding Relationships: We have deep relationships with key industry participants and investors, ensuring we know what is relevant to the market and what drives value.
Healthcare Transactions
Serving as financial advisor to Advent International on its acquisition of PatientPoint
August 2025
Served as financial advisor to PharmaLogic, a portfolio company of Webster Equity Partners and MedEquity Capital, on its acquisition of Agilera Pharma AS
June 2025
Served as financial advisor to GE HealthCare on its acquisition of the remaining 50% stake in Nihon Medi-Physics
June 2025
Served as financial advisor to GetixHealth, a portfolio company of H.I.G. Capital, on its acquisition of Americollect
June 2025
Serving as financial advisor to Lantheus on the pending sale of its SPECT business to SHINE Technologies
May 2025
Served as financial advisor to Lantheus on its acquisition of Evergreen Theragnostics, with an upfront value of $275M and total value of up to $1B
April 2025
Served as financial advisor to Willow Innovations on its acquisition of Elvie
March 2025
Served as financial advisor to Guerbet on the sale of its Accurate Medical microcatheter assets to Argon Medical
January 2025
Served as financial advisor to Platinum Equity on its acquisition of ASP Global
August 2024
Served as financial advisor to SOFIE Biosciences on its growth investment from Trilantic North America
June 2024
Served as financial advisor to ARTMS Inc. on its sale
April 2024
Served as financial advisor to Lantheus on the sale of its Somerset facility to Perspective Therapeutics
March 2024
Served as financial advisor to Prime Therapeutics on its strategic alliance with and minority investment in Capital Rx
March 2024
Served as financial advisor to TIDI Products on its sale to TJC
December 2023
Served as financial advisor to lululemon on strategic alternatives for lululemon studio
September 2023
Served as financial advisor to Zavation on its acquisition of CoreLink
June 2023
Served as financial advisor to Wahoo Fitness on its recapitalization and growth financing
May 2023
Served as financial advisor to Prodigo Solutions on its sale to GHX, a portfolio company of Warburg Pincus and Temasek
April 2023
Served as the exclusive financial advisor and placement agent to Prime Therapeutics on its acquisition of Magellan Rx
December 2022
Served as financial advisor to ProSomnus on its merger with Lakeshore Acquisition I SPAC
December 2022
Served as financial advisor to Vestar Capital on its strategic growth investment in Nox Health
November 2022
Served as exclusive financial advisor to Panalgo on its sale to MMIT & Evaluate, a Welsh, Carson, Anderson & Stowe and Hg portfolio company
October 2021
Served as financial advisor to Truepill on its $142 million capital raise at a $1.6 billion valuation
October 2021
Served as strategic and financial advisor to Pharmaca Integrative on its sale to Medly Pharmacy
June 2021
Served as financial advisor to Under Armour on its sale of the MyFitnessPal Platform to Francisco Partners
December 2020
Served as exclusive financial advisor to PatientPoint in connection with the patient-physician engagement solutions provider's $140 million capital raise
from Searchlight Capital Partners and Silver Point Capital.
June 2017
Healthcare Specialists
Healthcare Insights
Navigating Opportunities and Challenges in Today’s Healthcare M&A Market
Subscribe Episode Description Solomon’s Head of Healthcare Jon Hammack and Partner Jon Pritti explore the dynamics shaping today’s healthcare M&A…
Industry Q&A — Trends and Opportunities for M&A in Behavioral Healthcare
by CEO Marc S. Cooper From COVID-19 and changing regulations to rising interest rates and inflation, the past few years…
Capital Advisory
Our Capital Advisory team works closely with clients to provide comprehensive, independent guidance throughout an organization’s life cycle.
Insights & Perspectives
Reports. Podcasts. Latest News. Explore our insights and perspectives on the latest industry trends and market developments.
M&A and Strategic Advisory
Our bankers provide strategic solutions across complex M&A assignments and advise boards and special committees on navigating highly scrutinized situations.